Literature DB >> 29760238

Structural and ligand-binding analysis of the YAP-binding domain of transcription factor TEAD4.

Yan Li1, Shuang Liu1, Elizabeth Yihui Ng1, Rong Li1, Anders Poulsen1, Jeffrey Hill1, Ajaybabu V Pobbati2, Alvin W Hung3, Wanjin Hong4, Thomas H Keller1, CongBao Kang3.   

Abstract

The oncoprotein YAP (Yes-associated protein) requires the TEAD family of transcription factors for the up-regulation of genes important for cell proliferation. Disrupting YAP-TEAD interaction is an attractive strategy for cancer therapy. Targeting TEADs using small molecules that either bind to the YAP-binding pocket or the palmitate-binding pocket is proposed to disrupt the YAP-TEAD interaction. There is a need for methodologies to facilitate robust and reliable identification of compounds that occupy either YAP-binding pocket or palmitate-binding pocket. Here, using NMR spectroscopy, we validated compounds that bind to these pockets and also identify the residues in mouse TEAD4 (mTEAD4) that interact with these compounds. Flufenamic acid (FA) was used as a positive control for validation of palmitate-binding pocket-occupying compounds by NMR. Furthermore, we identify a hit from a fragment screen and show that it occupies a site close to YAP-binding pocket on the TEAD surface. Our results also indicate that purified mTEAD4 can catalyze autopalmitoylation. NMR studies on mTEAD4 revealed that exchanges exist in TEAD as NMR signal broadening was observed for residues close to the palmitoylation site. Mutating the palmitoylated cysteine (C360S mutant) abolished palmitoylation, while no significant changes in the NMR spectrum were observed for the mutant which still binds to YAP. We also show that FA inhibits TEAD autopalmitoylation. Our studies highlight the utility of NMR spectroscopy in identifying small molecules that bind to TEAD pockets and reinforce the notion that both palmitate-binding pocket and YAP-binding pocket are targetable.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  NMR spectroscopy; drug discovery and design; palmitoylation; protein structure; protein–protein Introduction

Mesh:

Substances:

Year:  2018        PMID: 29760238     DOI: 10.1042/BCJ20180225

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

Review 1.  TEAD4 as an Oncogene and a Mitochondrial Modulator.

Authors:  Sheng-Chieh Hsu; Ching-Yu Lin; Yen-Yi Lin; Colin C Collins; Chia-Lin Chen; Hsing-Jien Kung
Journal:  Front Cell Dev Biol       Date:  2022-05-05

2.  Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3.

Authors:  Wei Zhou; Yiping Li; Jinhua Song; Chenglong Li
Journal:  Anal Biochem       Date:  2019-08-31       Impact factor: 3.365

Review 3.  A Practical Perspective on the Roles of Solution NMR Spectroscopy in Drug Discovery.

Authors:  Qingxin Li; CongBao Kang
Journal:  Molecules       Date:  2020-06-28       Impact factor: 4.411

Review 4.  GPCR-Hippo Signaling in Cancer.

Authors:  Jiaqian Luo; Fa-Xing Yu
Journal:  Cells       Date:  2019-05-08       Impact factor: 6.600

5.  Determination of the migration effect and molecular docking of verteporfin in different subtypes of breast cancer cells.

Authors:  Changran Wei; Xiangqi Li
Journal:  Mol Med Rep       Date:  2020-09-02       Impact factor: 2.952

6.  Discovery of Covalent Inhibitors Targeting the Transcriptional Enhanced Associate Domain Central Pocket.

Authors:  Hacer Karatas; Mohammad Akbarzadeh; Hélène Adihou; Gernot Hahne; Ajaybabu V Pobbati; Elizabeth Yihui Ng; Stéphanie M Guéret; Sonja Sievers; Axel Pahl; Malte Metz; Sarah Zinken; Lara Dötsch; Christine Nowak; Sasikala Thavam; Alexandra Friese; CongBao Kang; Wanjin Hong; Herbert Waldmann
Journal:  J Med Chem       Date:  2020-10-01       Impact factor: 7.446

Review 7.  Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine.

Authors:  Evan R Barry; Vladimir Simov; Iris Valtingojer; Olivier Venier
Journal:  Cells       Date:  2021-10-11       Impact factor: 6.600

Review 8.  A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.

Authors:  Ajaybabu V Pobbati; Wanjin Hong
Journal:  Theranostics       Date:  2020-02-18       Impact factor: 11.556

Review 9.  The Role of Photoactivated and Non-Photoactivated Verteporfin on Tumor.

Authors:  Changran Wei; Xiangqi Li
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810

10.  The interaction of TEA domain transcription factor 4 (TEAD4) and Yes-associated protein 1 (YAP1) promoted the malignant process mediated by serum/glucocorticoid regulated kinase 1 (SGK1).

Authors:  Songlin He; Hanlu Zhang; Zongwei Xiao; Sandeep Bhushan; Ke Gao; Wenping Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.